Benchmark your learning program against your peers
Among your life science peers, what is the main concern in the learning space?
How do they rate their own quality training programs?
What are their investment priorities?
Are they adopting new learning technologies, such as artificial intelligence, virtual reality and augmented reality?
What are inspectors finding upon audit?
The ComplianceWire® 2023 Compliance Learning Benchmarking Study delivers the answers to these questions and much more. This annual study conflates survey data and usage data from the ComplianceWire® platform into a comprehensive analysis of current trends in training science.
While many of the top 100 life science companies are represented, our sample includes companies of all sizes that represent a broad mix of internal stakeholders within those companies. In addition to a broad spectrum of the global life sciences industry, our sample includes learners not only from the United States Food and Drug Administration (FDA), but also:
- China’s National Medical Products Administration (NMPA)
- The Gujarat Food and Drugs Control Administration (FDCA) in India
- The Saudi Food & Drug Authority (SFDA)
ComplianceWire Benchmark Study 2023 Whitepapers
1.57 MB
Download your copy today!
To download the study, please fill out the form below:
Please wait…